Iovance Biotherapeutics
IOVA
$13.45
Share price
0.45%
Change (1 day)
89.97%
Change (1 year)
Categories
Iovance Biotherapeutics (IOVA) - Net assets
Net assets on the balance sheet as of December 2023 : $0.58 B
According to Iovance Biotherapeutics
's latest financial reports the company has $0.58 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Iovance Biotherapeutics - Net assets on balance sheet (from 2008 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.58 B | 17.01% |
| 2022-12-31 | $0.49 B | -19.63% |
| 2021-12-31 | $0.62 B | -5.31% |
| 2020-12-31 | $0.65 B | 119.59% |
| 2019-12-31 | $0.29 B | -35.87% |
| 2018-12-31 | $0.46 B | 220.45% |
| 2017-12-31 | $0.14 B | -12.84% |
| 2016-12-31 | $0.16 B | 60.46% |
| 2015-12-31 | $0.10 B | 131.96% |
| 2014-12-31 | $44.84 M | 154.75% |
| 2013-12-31 | $17.6 M | -255.52% |
| 2012-12-31 | $-11.32 M | -11.43% |
| 2011-12-31 | $-12.79 M | -2103.01% |
| 2010-12-31 | $0.63 M | -4830.76% |
| 2009-12-31 | $-0.02 M | -690.54% |
| 2008-12-31 | $0 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.88 M | -100.49% | Bahamas |
 NRC Health
NRC | $48.95 M | -91.63% | 🇺🇸 USA |